Everest Life Sciences LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 31 SCHALKS CROSSING RD, PLAINSBORO, New Jersey (NJ) 08536, United States (USA)
- Operations here
- analysisapi manufacturelabelmanufacturepackrepack
- FDA identifiers
- FEI 2243092 · DUNS 110774649
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-04-23
- VAIBioresearch Monitoring2018-10-23
- NAIDrug Quality Assurance2018-07-13
- NAIDrug Quality Assurance2016-03-16
- VAIDrug Quality Assurance2012-04-16
- VAIDrug Quality Assurance2011-02-18
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- Dapsone TabletsEverest Life Sciences. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.